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Summary
Administration to newborn pigs of an oral 
or intraperitoneal dose of equine-origin 
Clostridium difficile antitoxin 4 hours before 
orogastric inoculation with a swine-origin  
C difficile field isolate resulted in lower his-
topathology scores 72 hours post challenge 
than in pigs receiving no antitoxin (P  < .05).
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In the last 10 years, Clostridium difficile has been implicated as a major cause of neonatal diarrhea in pigs.1 Clostridium 
difficile infection (CDI) typically affects pig-
lets ranging in age from 1 to 7 days. Clinical 
signs of CDI include diarrhea, abdominal 
distention, and scrotal edema, with most of 
the pathology being attributed to toxins A 
and B.2 The prevalence of C difficile is wide-
spread in the United States and has been 
referred to as the most important uncon-
trolled cause of neonatal diarrhea in the pig.1 
This is supported by many studies indicating 
a prevalence rate of about 50% and the fact 
that C difficile may affect litter productivity 
by as much as 10% to  15%.1,3,4
In human medicine, intravenous administra-
tion of immunoglobulins for treatment of 
CDI has variable results.5-8 This variability 
may be due to differences in timing of anti-
body administration and toxin exposure.7 In a 
mouse model, McPherson et al5 reported that 
intravenous administration of immunoglobu-
lins is most effective when performed at the 
same time as toxin infusion. The use of pro-
phylactic antibiotics has been unsatisfactory 
and unrewarding for swine  producers.
The objective of this pilot study was to 
investigate if administration of an equine-
origin antitoxin would serve as a beneficial 
intervention in minimizing the clinical and 
histologic effects in neonatal pigs infected 
with C  difficile.
Materials and  methods
The experimental protocol was approved 
by the Iowa State University (ISU) Institu-
tional Animal Care and Use  Committee.
Animals and  housing
Thirty-six newborn piglets were obtained 
from a commercial farrowing unit. Parturi-
tion was monitored on-farm and all piglets 
were farrowed onto a sterile drape or manu-
ally removed to prevent contact with the 
environment, as described by Lizer et al.9 The 
piglets were immediately dried and placed in 
clean plastic totes under heat lamps. Colos-
trum was collected from farrowing sows and 
mixed to create a single pooled colostrum 
stock. All piglets were orogastrically intu-
bated and fed 10 mL of pooled colostrum, 
followed by 15 mL of milk replacer (Esbilac 
liquid puppy formula; Pet-Ag, Hampshire, 
Illinois), tagged, and transported back to ISU 
within 4 hours of birth. Pigs were randomly 
assigned to six groups (Table 1) using a 
random number generator (Excel; Microsoft, 
Redmond, Washington). Inoculated pigs 
(Groups D, E, and F) were housed in one 
room while non-inoculated pigs (Groups 
A, B, and C) were in a separate room to 
prevent cross-contamination. All pigs were 
Resumen - Uso de antitoxinas de origen 
equino en lechones antes de la exposición 
para mitigar los efectos de la infección de 
Clostridium difficile – un estudio piloto
La administración a cerdos recién nacidos 
de una dosis intraperitoneal u oral de la anti-
toxina Clostridium difficile de origen equino  
4 horas antes de la inoculación orogástrica 
con un aislado de campo de C difficile de 
origen porcino resultó en índices histopa-
tológicos más bajos 72 horas después del reto 
que en cerdos que no recibieron la antitoxina 
(P < .05). 
Résumé - Utilisation d’antitoxine d’origine 
équine chez des porcelets avant l’exposition 
afin de limiter les effets d’une infection par 
Clostridium difficile – une étude pilote
L’administration orale ou intra-péritonéale 
à des porcelets nouveau-nés d’une dose 
d’antitoxine contre Clostridium difficile 
d’origine équine 4 heures avant l’inoculation 
oro-gastrique d’un isolat de C difficile 
d’origine porcine a résulté en une diminution 
des pointages des lésions histopathologiques 
72 heures post-inoculation comparativement 
à des porcelets ne recevant aucune antitoxine 
(P < .05).
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Table 1: Experimental design for conventional newborn pigs receiving saline or an oral or intraperitoneal dose of equine-origin 
Clostridium difficile antitoxin and inoculated 4 hours later with sham inoculum (non-infected) or C difficile spores (infected)
Treatment group Analysis group* No. of pigs Treatment† Inoculation‡
A NI 4 Saline Sham
B NI 4 Oral antibodies Sham
C NI 4 IP antibodies Sham
D IA 8 Oral antibodies C difficile
E IA 8 IP antibodies C difficile
F I 8 Saline C difficile
*  For purposes of statistical analysis, treatment groups were further categorized as NI (non-infected), IA (infected and received antibodies), 
or I (infected but received no antibodies).
† Treatments: either oral saline (control) or equine plasma from horses hyperimmunized against C difficile toxins A and B (Mg Biologics, Ames, 
Iowa) administered either orally or intraperitoneally (IP).
‡  Pigs were inoculated orogastrically either with sham inoculum (phosphate buffered saline; NI) or with  2 × 109 C difficile spores 4 hours 
after receiving treatment of either saline (I), or oral or IP antibodies (IA).
individually housed in raised plastic decks 
partitioned into individual pens (approxi-
mately 0.7 × 0.7 m) with solid dividing walls 
and individual feeding bowls as described by 
Lizer et al.9 Pigs were fed milk replacer three 
times daily for the duration of the experi-
ment (72  hours).
Study  design
Pigs in groups B, C, D, and E (Table 1) 
received an oral or intraperitoneal (IP) dose 
of equine-origin Clostridium difficile anti-
toxin, and pigs in groups A and F received a 
saline placebo. Toxin-neutralizing antitoxin 
was administered at the same time as pooled 
colostrum. Serum samples from all pigs were 
tested for circulating toxin-neutralizing 
antibodies prior to administration of 
colostrum and antitoxin, and 24 hours post 
 administration.
Inoculum
Inoculum preparation was performed as 
described by Lizer et al.9 Briefly, pure pellets 
of C difficile (ISU isolate 13912–1) with a 
concentration of 2 × 109 spores per mL were 
used as the inoculum. This isolate is a 2008 
field isolate from a 2-day-old scouring pig 
from northern Missouri that was submitted 
to ISU Veterinary Diagnostic Laboratory. 
Immediately prior to challenge, spores were 
heat shocked in a water bath at 80°C for 10 
minutes. Brain heart infusion broth with 
0.1% taurocholic acid and 5% fetal bovine 
serum was added to the heated spore suspen-
sion at a concentration of 25% volume per 
volume (v/v) and incubated 1 hour at 37°C. 
Sterile phosphate buffered saline was used in 
the place of spores for controls (sham inocu-
lum). A 1.25-mL inoculum dose or phosphate 
buffered saline was administered via a sterile 
gastric tube and flushed with 20 mL milk 
replacer. Pigs were inoculated 4 hours post 
administration of colostrum and antitoxin or 
 saline.
Antitoxin
Equine plasma from horses hyperimmu-
nized against C difficile toxins A and B was 
obtained from Mg Biologics (Ames, Iowa). 
The hyperimmune equine plasma that was 
administered to the pigs had titers of 1:800 
and 1:1600 for toxins A and B, respectively. 
Titers were determined by cell neutraliza-
tion assay as  described below.
Antibodies
Toxin-neutralizing antibodies were assessed 
in cell culture using Chinese hamster ovary 
cells according to the protocol established by 
Post et al.10 Briefly, Chinese hamster ovary 
cells are exposed to dilutions of serum and 
known concentrations of toxins A and B. 
Toxin and serum are incubated for 1 hour 
at 37ºC prior to cell exposure. Twenty-
four hours later, the cells are assessed for 
cytopathic effect. The last dilution where 
no cytopathic effect is observed is reported 
as the antitoxin titer. The pooled colostrum 
sample was also tested for antibodies to 
toxins A and  B.
Necropsy and  histopathology
All pigs were euthanized by an intravenous 
overdose of pentobarbital at 72 hours post 
inoculation. At necropsy, weight, body 
condition (0 = normal, 1 = thin, 2 = emaci-
ated), stomach fill (0 = empty, 1 = half full, 
2 = full), consistency of large intestinal con-
tents (0 = firm, 1 = normal, 2 = pudding-
like, 3 = watery) were assessed with their 
respective scales, while dehydration, fecal 
staining of the perineum (used as a proxy for 
diarrhea), visible colonic necrosis and fibrin, 
and mesocolonic edema were assessed using 
a scale from 0 to 3 (0 = none, 1 = mild, 2 = 
moderate, 3 = severe) in a blinded fashion as 
previously  described.4,9
Formalin-fixed tissues collected for his-
topathology included ileum, jejunum, 
descending colon, cecum, and a cross section 
through the spiral colon containing four to 
five loops. Tissues were evaluated for goblet 
cells, quantity of neutrophils in the lamina 
propria, mucosal alterations (ulcers and ero-
sions), and mesenteritis (Lizer et  al).9
Bacterial culture and toxin 
 detection
After necropsy, spiral colon contents were 
cultured directly onto C difficile selective agar 
(CDSA; Remel, Lenexa, Kansas) in addi-
tion to routine aerobic and anaerobic plates. 
Toxin swabs collected from the rectum prior 
to inoculation and 48 and 72 hours post 
inoculation were assayed with a commercially 
available C. difficile Tox A/B II ELISA kit 
(TechLab, Blacksburg, Virginia) and analyzed 
on a microplate reader to grade the toxin 
levels on a scale from 0 through 4+ per manu-
facturer  recommendations.
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Statistical  analysis
In analyzing the data, we combined scores 
into three general categories: clinical signs, 
gross lesions, and microscopic lesions. The 
scoring system for each category was based 
on that published by Lizer et al.9 Clinical 
sign scores were calculated by summing 
scores for body condition, dehydration, and 
perineal staining. Gross lesions included the 
summed scores of necrotizing lesions, meso-
colonic edema, toxigenic culture, and toxin. 
Microscopic lesion scores were the sum of all 
histopathology changes noted. For statistical 
analysis, pigs in groups A, B, and C were 
combined in Group NI (non-infected), pigs 
in groups D and E were combined in Group 
IA (infected and received antitoxin), and 
pigs in Group F were in Group I (infected 
only), as summarized in Table 1. Statistical 
differences (P < .05) in group outcomes 
were determined by ANOVA, Tukey’s hon-
estly significant difference (HSD) test, and 
Fisher’s exact test using JMP Pro 10 (SAS; 
Cary, North Carolina) statistical  software.
Results
Antibodies for toxins A and B were not 
detected in the pooled colostrum sample 
or in the serum sample from any pig prior 
to administration of hyperimmune equine 
plasma. Twenty-four hours later, all pigs that 
had received antitoxin either by IP or oral 
administration (groups B, C, D, and E) had 
measurable levels of circulating antitoxin. All 
but one pig (Group B, titer 1:2) had toxin-
neutralizing titers of 1:16 or greater. Pigs that 
had not received antitoxin had no detectable 
antibodies to C difficile toxins 24 hours post 
administration of  colostrum.
Clostridium difficile was isolated from the 
colon of all inoculated pigs at necropsy. One 
pig from Group A and one from Group B 
were culture-positive for C difficile at the end 
of the study and were excluded from all analy-
ses. Both were from non-infected groups. 
Additionally, C difficile toxin was detected 
in six of the 16 pigs (37.5%) in group IA and 
four of the eight pigs (50.0%) in group  I.
At the time of colostrum administration, 
mean body weight was 1.38 kg (SD 0.263). 
At 72 hours post challenge, the mean weights 
of the infected pigs (Group D, E, and F; 1.26 
kg, SD 0.264) and non-infected pigs (Group 
A, B, and C; 1.40 kg, SD 0.329) did not 
differ (P = .21). Additionally, at necropsy, 
mean weights of infected pigs not receiving 
antitoxin (Group F; 1.21 kg, SD 0.270) and 
of those that did receive antitoxin (groups 
D and E; 1.29 kg, SD 0.265) did not differ 
(P  = .46).
Results of scoring at necropsy are summarized 
in Table 2. There were no statistical differ-
ences in means among the groups. Two pigs 
in the I group and two in the IA group had 
mesocolonic edema. In the I group, both pigs 
had moderate edema, and in the IA group, 
one had mild and the other moderate edema. 
Intestinal content consistency did not differ 
among pigs regardless of treatment group. 
Gross intestinal lesions were not  observed.
Microscopic lesions were summed to provide 
a total microscopic lesion score. Mean total 
scores for NI (2.90, SD 0.526) and IA pigs 
(3.69, SD 0.561) did not differ (P = .86). 
However, mean total score did differ between 
animals in Group I (7.88, SD 2.467) and 
either Group NI (P = .02) or Group IA  
(P  = .04).
Discussion
Lower total microscopic lesion scores in 
infected pigs receiving antitoxin either orally 
or IP suggest a beneficial effect of adminis-
tration of antitoxin prior to exposure to  
C difficile. Other parameters measured dif-
fered numerically in groups treated with 
antitoxin, but due to small sample sizes and 
wide variances in the groups they were not 
statistically significant. Although perineal 
staining did not differ among groups, it is 
interesting to note that all pigs from Group 
I had some degree of staining at necropsy, 
while five pigs in Group NI and five in 
Group IA had no  staining.
Results of this pilot study also support find-
ings by McPherson et al5 in that intravenous 
administration of immunoglobulins can be 
effective in protecting mice when adminis-
tered at the time of exposure. This interven-
tion can easily be performed under routine 
swine production practices, as CDI is often 
predictable within a particular swine opera-
tion. Although our study size was small, 
there appeared to be no clinical or statisti-
cal difference in the parameters measured 
between pigs treated with immunoglobulins 
IP or orally. In routine field settings, oral 
administration would be simpler and less 
invasive for the pigs, assuming they are 
treated before gut closure has  occurred.
In this study, we used harvested plasma 
containing immunoglobulins that had 
been specifically targeted against C difficile 
A and B toxins. Human studies5-8 utilize 
immunoglobulins obtained from pooled 
human blood and containing antibodies 
to many different antigens. The ability to 
obtain plasma with high levels of C difficile 
A and B antitoxins maximizes the potential 
for effectiveness. The plasma used in this 
study is now available commercially (AbSo-
lution Pg, Mg Biologics) at an approximate 
cost of  US $0.50 per  pig.
Our study was not designed to evaluate the 
effect of inoculation dose on CDI lesions. 
Prior work11has demonstrated that the dose 
of inoculum does appear to affect the sever-
ity of clinical and histopathologic lesions 
associated with CDI. The inoculum dose 
used in the present study was very high. The 
effectiveness of the antitoxin antibodies 
may even be greater under natural settings, 
although we did not study  this.
Implications
•	 Lower	total	microscopic	lesion	scores	
in treated piglets in this study suggest 
beneficial effects from administration of 
antitoxin prior to exposure to C difficile 
in  piglets.
•	 Under	the	conditions	of	this	study,	
in piglets treated before gut closure 
occurs, oral administration of C difficile 
antitoxin may be more practical than 
IP administration under routine field 
 settings.
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